LifeStance Health (LFST) Gains from Investment Securities (2021 - 2026)

LifeStance Health has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $23.9 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 100.05% year-over-year to $23.9 million; the TTM figure through Mar 2026 stood at $32.2 million (up 169.4% YoY), while the FY2025 annual figure was $13.5 million, down 1.43% from the prior year.
• Gains from Investment Securities climbed to $23.9 million in Q1 2026, from $10.1 million in the prior quarter.
• Over the last five years, Gains from Investment Securities for LFST reached as high as $23.9 million in Q1 2026 and fell as low as -$1.4 million in Q4 2024.
• The 5-year median for Gains from Investment Securities is $32396.0 (2022), against an average of $6.1 million.
• The widest YoY moves for Gains from Investment Securities: up 103761.54% in 2024, down 243.99% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at -$482000.0 in 2022, then rose by 13.69% to -$416000.0 in 2023, then tumbled by 243.99% to -$1.4 million in 2024, then surged by 808.94% to $10.1 million in 2025, then surged by 135.94% to $23.9 million in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $23.9 million, $10.1 million, and $13.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.